PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Spideyboy]

Following up with my last post, with such a long post I realise I had been too engrossed in looking at PRX-102.

There is of course the sales of Elelyso to Pfizer and Brazil to take into account, which adds about another 20 million to the revenues. Though adding maximum 10 million profit from those sales.

So about 90-100 million in profit from product sold. Still again essentially keeping a 1.4 - 1.8 billion valuation after both EMA & FDA approvals.

I would be keen to see what the analysts think post-approvals.